Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01897571
Brief Title: Open-Label, Multicenter, Phase 1/2 Study of Tazemetostat (EZH2 Histone Methyl Transferase [HMT] Inhibitor) as a Single Agent in Subjects With Adv. Solid Tumors or With B-cell Lymphomas and Tazemetostat in Combination With Prednisolone in Subjects With DLBCL

First Submitted : June 21, 2013
First Submitted that Met QC Criteria : July 9, 2013
First Posted : July 12, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : January 5, 2021
Last Update Posted : January 7, 2021